Fresenius Medical Care Receives FDA Breakthrough Device Designation for New Dialysis System to Prevent Blood Clotting Without the Use of Blood Thinners
25 October 2019
Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, announced today that the U.S. Food and Drug Administration (FDA) has granted br
